More than half of EU adults are overweight, while one in six is classified as obese; it’s a growing problem for healthcare ...

Investing.com - Argus upgraded Herbalife (NYSE:HLF) from Hold to Buy with a price target of $15, citing expected revenue growth from new products. The target represents over 20% upside from the ...

What Happened? Shares of health and wellness products company Herbalife (NYSE:HLF) fell 2.8% in the morning session after ...

Detailed price information for Interparfums Inc (IPAR-Q) from The Globe and Mail including charting and trades.

Eli Lilly and Novo Nordisk — the dominant players in obesity drug development — each submitted a new weight-loss drug to the ...

Eli Lilly said its next generation weight-loss drug retatrutide resulted in significant weight loss and reduced knee pain in ...

Eli Lilly just announced phase 3 clinical trial results for its new medication, retatrutide, and it could become the most ...

Herbalife (HLF) just gave investors a fresh reality check, with shrinking unit sales, muted demand forecasts, and regulatory worries keeping sentiment cautious despite a recent upgrade that briefly ...

The best time to take berberine may be with or just before meals when using it for weight loss and blood sugar control.

Discover the top 11 websites to buy GLP-1 weight loss medications online. Our expert-reviewed guide helps you find safe, ...

In a recent, vulnerable Instagram post, the Trainwreck star addressed rumors surrounding her marriage to Chris Fischer, as well as insight into her major weight loss journey. “I didn’t lose 30lbs, I ...

You may have heard of the obesity paradox—the concept that older adults who are overweight or even mildly obese may have better health outcomes than those who are at a “normal” weight. While there’s ...